A detailed history of Stonehaven Wealth & Tax Solutions, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stonehaven Wealth & Tax Solutions, LLC holds 5,182 shares of BMY stock, worth $241,740. This represents 0.33% of its overall portfolio holdings.

Number of Shares
5,182
Previous 4,835 7.18%
Holding current value
$241,740
Previous $273 Million 15.57%
% of portfolio
0.33%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$53.9 - $63.11 $18,703 - $21,899
347 Added 7.18%
5,182 $316 Million
Q4 2024

Feb 13, 2025

BUY
$51.92 - $59.94 $251,033 - $289,809
4,835 New
4,835 $273 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stonehaven Wealth & Tax Solutions, LLC Portfolio

Follow Stonehaven Wealth & Tax Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehaven Wealth & Tax Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonehaven Wealth & Tax Solutions, LLC with notifications on news.